BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 18824002)

  • 1. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role for human P-glycoprotein in the transport of lacosamide.
    Zhang C; Chanteux H; Zuo Z; Kwan P; Baum L
    Epilepsia; 2013 Jul; 54(7):1154-60. PubMed ID: 23551115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
    Zhang C; Kwan P; Zuo Z; Baum L
    Life Sci; 2010 Jun; 86(23-24):899-905. PubMed ID: 20417647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines.
    Ambroziak K; Kuteykin-Teplyakov K; Luna-Tórtos C; Al-Falah M; Fedrowitz M; Löscher W
    Eur J Pharmacol; 2010 Feb; 628(1-3):57-66. PubMed ID: 19958760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
    Weiss J; Kerpen CJ; Lindenmaier H; Dormann SM; Haefeli WE
    J Pharmacol Exp Ther; 2003 Oct; 307(1):262-7. PubMed ID: 12954800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
    Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
    Zhang C; Zuo Z; Kwan P; Baum L
    Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
    Römermann K; Helmer R; Löscher W
    Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro transport assays of rufinamide, pregabalin, and zonisamide by human P-glycoprotein.
    Chan PS; Zhang C; Zuo Z; Kwan P; Baum L
    Epilepsy Res; 2014 Mar; 108(3):359-66. PubMed ID: 24530088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
    Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
    He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
    Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
    Bankstahl JP; Löscher W
    Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs.
    Hung CC; Chen CC; Lin CJ; Liou HH
    Pharmacogenet Genomics; 2008 May; 18(5):390-402. PubMed ID: 18408562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.
    Volk HA; Löscher W
    Brain; 2005 Jun; 128(Pt 6):1358-68. PubMed ID: 15716304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
    Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys.
    Tang C; Kuo Y; Pudvah NT; Ellis JD; Michener MS; Egbertson M; Graham SL; Cook JJ; Hochman JH; Prueksaritanont T
    Biochem Pharmacol; 2009 Sep; 78(6):642-7. PubMed ID: 19481060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains.
    Lü Y; Yan Y; Wang XF
    Chin Med J (Engl); 2004 Nov; 117(11):1682-6. PubMed ID: 15569486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.